Chronic Heart Failure in Congenital Heart Disease: A Scientific Statement from the American Heart Association

Circulation

Volumn 133, Issue 8, 2016, Pages 770-801

  Stout, Karen K ^a   Broberg, Craig S ^a   Book, Wendy M ^a   Cecchin, Frank ^a   Chen, Jonathan M ^a   Dimopoulos, Konstantinos ^a   Everitt, Melanie D ^a   Gatzoulis, Michael ^a   Harris, Louise ^a   Hsu, Daphne T ^a   Kuvin, Jeffrey T ^a   Law, Yuk ^a   Martin, Cindy M ^a   Murphy, Anne M ^a   Ross, Heather J ^a   Singh, Gautam ^a   Spray, Thomas L ^a  

^a NONE

Author keywords

AHA Scientific Statements; congenital heart defects; Fontan procedure; heart failure; right ventricle; tetralogy of Fallot; transposition of the great vessels; ventricular remodeling

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CAVOPULMONARY CONNECTION; CONGENITAL HEART DISEASE; DIASTOLIC DYSFUNCTION; DISEASE CLASSIFICATION; DISEASE COURSE; EARLY DIAGNOSIS; ENZYME INHIBITION; FONTAN PROCEDURE; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART SINGLE VENTRICLE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PATIENT; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VALVE INSUFFICIENCY; SINUS NODE DISEASE; SUPRAVENTRICULAR TACHYCARDIA; SURVIVAL; VENTRICULAR ASSIST DEVICE; CHRONIC DISEASE; HEART DEFECTS, CONGENITAL; UNITED STATES;

AMERICAN HEART ASSOCIATION; CHRONIC DISEASE; HEART DEFECTS, CONGENITAL; HEART FAILURE; HUMANS; UNITED STATES;

EID: 84959160569     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000352     Document Type: Article

References (313)

1. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA, del Nido P, Fasules JW, Graham TP Jr, Hijazi ZM, Hunt SA, King ME, Landzberg MJ, Miner PD, Radford MJ, Walsh EP, Webb GD. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Circulation. 2008;118:e714-e833. doi: 10.1161/CIRCULATIONAHA.108.190690.
2. Connelly MS, Webb GD, Somerville J, Warnes CA, Perloff JK, Liberthson RR, Puga FJ, Collins-Nakai RL, Williams WG, Mercier LA, Huckell VF, Finley JP, McKay R. Canadian Consensus Conference on Adult Congenital Heart Disease 1996. Can J Cardiol. 1998;14:395-452.
3. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task Force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:1170-1175.
4. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B?m M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K?er L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R?nevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology [published correction appears in Eur J Heart Fail. 2013;15:361-362].
5. Eur J Heart Fail. 2012;14:803-869. doi: 10.1093/eurjhf/hfs105.
6. Heart Failure Society of America. Executive summary: HFSA 2006 comprehensive heart failure practice guideline. J Card Fail. 2006;12:10-38.
7. Tobler D, Greutmann M, Colman JM, Greutmann-Yantiri M, Librach LS, Kovacs AH. End-of-life care in hospitalized adults with complex congenital heart disease: care delayed, care denied. Palliat Med. 2012;26:72-79. doi: 10.1177/0269216311407694.
8. Hoffman JI, Kaplan S, Liberthson RR. Prevalence of congenital heart disease. Am Heart J. 2004;147:425-439. doi: 10.1016/j.ahj.2003.05.003.
9. Tennant PW, Pearce MS, Bythell M, Rankin J. 20-Year survival of children born with congenital anomalies: a population-based study. Lancet. 2010;375:649-656. doi: 10.1016/S0140-6736(09)61922-X.
10. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8:50-60. doi: 10.1038/nrcardio.2010.166.
11. Wren C, O'Sullivan JJ. Survival with congenital heart disease and need for follow up in adult life. Heart. 2001;85:438-443.
12. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122:2264-2272. doi: 10.1161/CIRCULATIONAHA.110.946343.
13. Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation. 2010;122:2254-2263. doi: 10.1161/CIRCULATIONAHA.110.947002.
14. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol. 2010;56:1149-1157. doi: 10.1016/j.jacc.2010.03.085.
15. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172. doi: 10.1161/CIRCULATIONAHA.106.627224.
16. Moons P, Engelfriet P, Kaemmerer H, Meijboom FJ, Oechslin E, Mulder BJ; Expert Committee of Euro Heart Survey on Adult Congenital Heart Disease. Delivery of care for adult patients with congenital heart disease in Europe: results from the Euro Heart Survey. Eur Heart J. 2006;27:1324-1330. doi: 10.1093/eurheartj/ehi858.
17. Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE Jr, Earing MG. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011;6:190-201. doi: 10.1111/j.1747-0803.2011.00504.x.
18. van der Bom T, Luijendijk P, Bouma BJ, Koolbergen DR, de Groot JR, Mulder BJ, Mulder BB. Treatment of congenital heart disease: risk-reducing measures in young adults [published correction appears in Future Cardiol. 2011;7:441].
19. Future Cardiol. 2011;7:227-240. doi: 10.2217/fca.11.5.
20. Mackie AS, Pilote L, Ionescu-Ittu R, Rahme E, Marelli AJ. Health care resource utilization in adults with congenital heart disease. Am J Cardiol. 2007;99:839-843. doi: 10.1016/j.amjcard.2006.10.054.
21. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54:460-467. doi: 10.1016/j.jacc.2009.04.037.
22. Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, Vliegen HW, Grobbee DE, Mulder BJ. Mortality in adult congenital heart disease. Eur Heart J. 2010;31:1220-1229. doi: 10.1093/eurheartj/ehq032.
23. Norozi K, Wessel A, Alpers V, Arnhold JO, Geyer S, Zoege M, Buchhorn R. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol. 2006;97:1238-1243. doi: 10.1016/j.amjcard.2005.10.065.
24. Piran S, Veldtman G, Siu S, Webb GD, Liu PP. Heart failure and ventricular dysfunction in patients with single or systemic right ventricles. Circulation. 2002;105:1189-1194.
25. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol. 2007;50:1263-1271. doi: 10.1016/j.jacc.2007.05.040.
26. Oechslin EN, Harrison DA, Connelly MS, Webb GD, Siu SC. Mode of death in adults with congenital heart disease. Am J Cardiol. 2000;86:1111-1116.
27. Zomer AC, Vaartjes I, Uiterwaal CS, van der Velde ET, van den Merkhof LF, Baur LH, Ansink TJ, Cozijnsen L, Pieper PG, Meijboom FJ, Grobbee DE, Mulder BJ. Circumstances of death in adult congenital heart disease. Int J Cardiol. 2012;154:168-172. doi: 10.1016/j.ijcard.2010.09.015.
28. Zomer AC, Vaartjes I, van der Velde ET, de Jong HM, Konings TC, Wagenaar LJ, Heesen WF, Eerens F, Baur LH, Grobbee DE, Mulder BJ. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol. 2013;168:2487-2493. doi: 10.1016/j. ijcard.2013.03.003.
29. Kirk R, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Dobbels F, Rahmel AO, Stehlik J, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official pediatric heart transplantation report-2010. J Heart Lung Transplant. 2010;29:1119-1128. doi: 10.1016/j.healun.2010.08.009.
30. Stehlik J, Edwards LB, Kucheryavaya AY, Aurora P, Christie JD, Kirk R, Dobbels F, Rahmel AO, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult heart transplant report-2010. J Heart Lung Transplant. 2010;29:1089-1103. doi: 10.1016/j.healun.2010.08.007.
31. Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, Kirklin JK; Cardiac Transplant Registry Database; Pediatric Heart Transplant Study. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54:160-165. doi: 10.1016/j. jacc.2009.04.020.
32. Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, Galantowicz ME, Lamour JM, Quaegebeur JM, Hsu DT. Cardiac transplantation after the Fontan or Glenn procedure. J Am Coll Cardiol. 2004;44:2065-2072. doi: 10.1016/j.jacc.2004.08.031.
33. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, Johansson B, Bouzas B, Mullen MJ, Poole-Wilson PA, Francis DP, Gatzoulis MA. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation. 2005;112:828-835. doi: 10.1161/CIRCULATIONAHA.104.529800.
34. Hsu DT, Pearson GD. Heart failure in children, part I: history, etiology, and pathophysiology. Circ Heart Fail. 2009;2:63-70. doi: 10.1161/CIRCHEARTFAILURE.108.820217.
35. Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. Boston, MA: Little, Brown, & Co; 1994.
36. Rosenthal D, Chrisant MR, Edens E, Mahony L, Canter C, Colan S, Dubin A, Lamour J, Ross R, Shaddy R, Addonizio L, Beerman L, Berger S, Bernstein D, Blume E, Boucek M, Checchia P, Dipchand A, Drummond-Webb J, Fricker J, Friedman R, Hallowell S, Jaquiss R, Mital S, Pahl E, Pearce B, Rhodes L, Rotondo K, Rusconi P, Scheel J, Pal Singh T, Towbin J. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children Heart Lung Transplant. 2009;28:987
37. J Heart Lung Transplant. 2004;23:1313-1333. doi: 10.1016/j.healun.2004.03.018.
38. Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522-523.
39. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64:1227-1234.
40. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2010;121:e258]. Circulation. 2009;119:e391-e479. doi: 10.1161/CIRCULATIONAHA.109.192065.
41. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH, Fonarow GC, Geraci SA, Horwich T, Januzzi JL, Johnson MR, Kasper EK, Levy WC, Masoudi FA, McBride PE, McMurray JJ, Mitchell JE, Peterson PN, Riegel B, Sam F, Stevenson LW, Tang WH, Tsai EJ, Wilkoff BL. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:1810-1852. doi: 10.1161/CIR.0b013e31829e8807.
42. Acker MA, Pagani FD, Stough WG, Mann DL, Jessup M, Kormos R, Slaughter MS, Baldwin T, Stevenson L, Aaronson KD, Miller L, Naftel D, Yancy C, Rogers J, Teuteberg J, Starling RC, Griffith B, Boyce S, Westaby S, Blume E, Wearden P, Higgins R, Mack M. Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail. 2013;6:e1-e11. doi: 10.1161/HHF.0b013e318279f6b5.
43. Bolger AP, Coats AJ, Gatzoulis MA. Congenital heart disease: the original heart failure syndrome. Eur Heart J. 2003;24:970-976.
44. Sanchez-Quintana D, Climent V, Ho SY, Anderson RH. Myoarchitecture and connective tissue in hearts with tricuspid atresia. Heart. 1999;81:182-191.
45. Sedmera D. Form follows function: developmental and physiological view on ventricular myocardial architecture. Eur J Cardiothorac Surg. 2005;28:526-528. doi: 10.1016/j.ejcts.2005.07.001.
46. Black BL. Transcriptional pathways in second heart field development. Semin Cell Dev Biol. 2007;18:67-76. doi: 10.1016/j.semcdb.2007.01.001.
47. Tobita K, Keller BB. Right and left ventricular wall deformation patterns in normal and left heart hypoplasia chick embryos. Am J Physiol Heart Circ Physiol. 2000;279:H959-H969.
48. St?li BE, Gebhard C, Biaggi P, Klaassen S, Valsangiacomo Buechel E, Attenhofer Jost CH, Jenni R, Tanner FC, Greutmann M. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol. 2013;167:2477-2481. doi: 10.1016/j.ijcard.2012.05.095.
49. Rutz T, de Marchi SF, Schwerzmann M, Vogel R, Seiler C. Right ventricular absolute myocardial blood flow in complex congenital heart disease. Heart. 2010;96:1056-1062. doi: 10.1136/hrt.2009.191718.
50. Lubiszewska B, Gosiewska E, Hoffman P, Teresi?ska A, R?a?ski J, Piotrowski W, Rydlewska-Sadowska W, Kubicka K, Ruzyo W. Myocardial perfusion and function of the systemic right ventricle in patients after atrial switch procedure for complete transposition: long-term follow-up. J Am Coll Cardiol. 2000;36:1365-1370.
51. Millane T, Bernard EJ, Jaeggi E, Howman-Giles RB, Uren RF, Cartmill TB, Hawker RE, Celermajer DS. Role of ischemia and infarction in late right ventricular dysfunction after atrial repair of transposition of the great arteries. J Am Coll Cardiol. 2000;35:1661-1668.
52. Fratz S, Hauser M, Bengel FM, Hager A, Kaemmerer H, Schwaiger M, Hess J, Stern HC. Myocardial scars determined by delayed-enhancement magnetic resonance imaging and positron emission tomography are not common in right ventricles with systemic function in long-term follow up. Heart. 2006;92:1673-1677. doi: 10.1136/hrt.2005.086579.
53. Singh TP, Humes RA, Muzik O, Kottamasu S, Karpawich PP, Di Carli MF. Myocardial flow reserve in patients with a systemic right ventricle after atrial switch repair. J Am Coll Cardiol. 2001;37:2120-2125.
54. Grewal J, Crean A, Garceau P, Wald R, Woo A, Rakowski H, Silversides CK. Subaortic right ventricular characteristics and relationship to exercise capacity in congenitally corrected transposition of the great arteries. J Am Soc Echocardiogr. 2012;25:1215-1221. doi: 10.1016/j.echo.2012.08.014.
55. Khairy P, Clair M, Fernandes SM, Blume ED, Powell AJ, Newburger JW, Landzberg MJ, Mayer JE Jr. Cardiovascular outcomes after the arterial switch operation for D-transposition of the great arteries. Circulation. 2013;127:331-339. doi: 10.1161/CIRCULATIONAHA.112.135046.
56. Ou P, Khraiche D, Celermajer DS, Agnoletti G, Le Quan Sang KH, Thalabard JC, Quintin M, Raisky O, Vouhe P, Sidi D, Bonnet D. Mechanisms of coronary complications after the arterial switch for transposition of the great arteries. J Thorac Cardiovasc Surg. 2013;145:1263-1269. doi: 10.1016/j.jtcvs.2012.06.009.
57. Hauser M, Bengel FM, K?n A, Sauer U, Nekolla SG, Eicken A, Schwaiger M, Hess J. Myocardial perfusion and coronary flow reserve assessed by positron emission tomography in patients after Fontan-like operations. Pediatr Cardiol. 2003;24:386-392. doi: 10.1007/s00246-002-0355-5.
58. Hauser M, Bengel FM, Hager A, Kuehn A, Nekolla SG, Kaemmerer H, Schwaiger M, Hess J. Impaired myocardial blood flow and coronary flow reserve of the anatomical right systemic ventricle in patients with congenitally corrected transposition of the great arteries. Heart. 2003;89:1231-1235.
59. Hauser M, Kuehn A, Hess J. Myocardial perfusion in patients with transposition of the great arteries after arterial switch operation. Circulation. 2003;107:e126; author reply e126. doi: 10.1161/01.CIR.0000071211.20538.25.
60. Sluysmans T, Sanders SP, van der Velde M, Matitiau A, Parness IA, Spevak PJ, Mayer JE Jr, Colan SD. Natural history and patterns of recovery of contractile function in single left ventricle after Fontan operation. Circulation. 1992;86:1753-1761.
61. Sugishita Y, Iida K, Ohtsuka S, Yamaguchi I. Ventricular wall stress revisited: a keystone of cardiology. Jpn Heart J. 1994;35:577-587.
62. Lang RE, Th?ken H, Ganten D, Luft FC, Ruskoaho H, Unger T. Atrial natriuretic factor: a circulating hormone stimulated by volume loading. Nature. 1985;314:264-266.
63. Scammell AM, Diver MJ. Plasma renin activity in infants with congenital heart disease. Arch Dis Child. 1987;62:1136-1138.
64. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, Temma S, Shirakami G, Imura H, Mikawa H. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation. 1991;84:2280-2285.
65. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation. 2002;106:92-99.
66. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, Yagihara T, Echigo S. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation. 2003;108:2368-2376. doi: 10.1161/01. CIR.0000101681.27911.FA.
67. Lang RE, Unger T, Ganten D, Weil J, Bidlingmaier F, Dohlemann D. Alpha atrial natriuretic peptide concentrations in plasma of children with congenital heart and pulmonary diseases. Br Med J (Clin Res Ed). 1985;291:1241.
68. Hopkins WE, Hall C. Paradoxical relationship between N-terminal proatrial natriuretic peptide and filling pressure in adults with cyanotic congenital heart disease. Circulation. 1997;96:2215-2220.
69. Tulevski II, Groenink M, van Der Wall EE, van Veldhuisen DJ, Boomsma F, Stoker J, Hirsch A, Lemkes JS, Mulder BJ. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction. Heart. 2001;86:27-30.
70. Reardon LC, Williams RJ, Houser LS, Miner PD, Child JS, Aboulhosn JA. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. Am J Cardiol. 2012;110:1523-1526. doi: 10.1016/j.amjcard.2012.06.061.
71. Fuster V, Danielson MA, Robb RA, Broadbent JC, Brown AL Jr, Elveback LR. Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload. Circulation. 1977;55:504-508.
72. Hein S, Arnon E, Kostin S, Schburg M, Elsser A, Polyakova V, Bauer EP, Klekorn WP, Schaper J. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984-991.
73. Chowdhury UK, Sathia S, Ray R, Singh R, Pradeep KK, Venugopal P. Histopathology of the right ventricular outflow tract and its relationship to clinical outcomes and arrhythmias in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg. 2006;132:270-277. doi: 10.1016/j. jtcvs.2006.04.001.
74. Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, Khan M, Ho SY, Pennell DJ, Gatzoulis MA. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405-413. doi: 10.1161/CIRCULATIONAHA.105.548727.
75. Babu-Narayan SV, Goktekin O, Moon JC, Broberg CS, Pantely GA, Pennell DJ, Gatzoulis MA, Kilner PJ. Late gadolinium enhancement cardiovascular magnetic resonance of the systemic right ventricle in adults with previous atrial redirection surgery for transposition of the great arteries. Circulation. 2005;111:2091-2098. doi: 10.1161/01.CIR.0000162463.61626.3B.
76. Broberg CS, Prasad SK, Carr C, Babu-Narayan SV, Dimopoulos K, Gatzoulis MA. Myocardial fibrosis in Eisenmenger syndrome: a descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival. J Cardiovasc Magn Reson. 2014;16:32. doi: 10.1186/1532-429X-16-32.
77. Rathod RH, Prakash A, Powell AJ, Geva T. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation. J Am Coll Cardiol. 2010;55:1721-1728. doi: 10.1016/j. jacc.2009.12.036.
78. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging. 2010;3:727-734. doi: 10.1161/CIRCIMAGING.108.842096.
79. Krymsky LD. Pathologic anatomy of congenital heart disease. Circulation. 1965;32:814-827.
80. Salih C, McCarthy KP, Ho SY. The fibrous matrix of ventricular myocardium in hypoplastic left heart syndrome: a quantitative and qualitative analysis. Ann Thorac Surg. 2004;77:36-40.
81. Gatzoulis MA, Till JA, Somerville J, Redington AN. Mechanoelectrical interaction in tetralogy of Fallot: QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. Circulation. 1995;92:231-237.
82. Lenfant C. Report of the Task Force on Research in Pediatric Cardiovascular Disease. Circulation. 2002;106:1037-1042.
83. Senzaki H, Masutani S, Kobayashi J, Kobayashi T, Sasaki N, Asano H, Kyo S, Yokote Y, Ishizawa A. Ventricular afterload and ventricular work in Fontan circulation: comparison with normal two-ventricle circulation and single-ventricle circulation with Blalock-Taussig shunts Circulation. 2012;125:e1020
84. Circulation. 2002;105:2885-2892.
85. Szab G, Buhmann V, Graf A, Melnitschuk S, Brle S, Vahl CF, Hagl S. Ventricular energetics after the Fontan operation: contractility-afterload mismatch. J Thorac Cardiovasc Surg. 2003;125:1061-1069. doi: 10.1067/mtc.2003.405.
86. de Leval MR. The Fontan circulation: a challenge to William Harvey Nat Clin Pract Cardiovasc Med. 2005;2:202-208. doi: 10.1038/ncpcardio0157.
87. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol. 2004;93:1374-1377, A6. doi: 10.1016/j.amjcard.2004.02.033.
88. Broberg CS, Aboulhosn J, Mongeon FP, Kay J, Valente AM, Khairy P, Earing MG, Opotowsky AR, Lui G, Gersony DR, Cook S, Ting JG, Webb G, Gurvitz MZ; Alliance for Adult Research in Congenital Cardiology (AARCC). Prevalence of left ventricular systolic dysfunction in adults with repaired tetralogy of Fallot. Am J Cardiol. 2011;107:1215-1220. doi: 10.1016/j.amjcard.2010.12.026.
89. Engelfriet P, Boersma E, Oechslin E, Tijssen J, Gatzoulis MA, Thil U, Kaemmerer H, Moons P, Meijboom F, PopelovJ, Laforest V, Hirsch R, Daliento L, Thaulow E, Mulder B. The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period: the Euro Heart Survey on adult congenital heart disease. Eur Heart J. 2005;26:2325-2333. doi: 10.1093/eurheartj/ehi396.
90. Dimopoulos K, Diller GP, Piepoli MF, Gatzoulis MA. Exercise intolerance in adults with congenital heart disease. Cardiol Clin. 2006;24:641-660, vii. doi: 10.1016/j.ccl.2006.08.002.
91. Alonso-Gonzalez R, Borgia F, Diller GP, Inuzuka R, Kempny A, Martinez-Naharro A, Tutarel O, Marino P, Wustmann K, Charalambides M, Silva M, Swan L, Dimopoulos K, Gatzoulis MA. Abnormal lung function in adults with congenital heart disease: prevalence, relation to cardiac anatomy, and association with survival. Circulation. 2013;127:882-890. doi: 10.1161/CIRCULATIONAHA.112.126755.
92. Broberg CS, Bax BE, Okonko DO, Rampling MW, Bayne S, Harries C, Davidson SJ, Uebing A, Khan AA, Thein S, Gibbs JS, Burman J, Gatzoulis MA. Blood viscosity and its relationship to iron deficiency, symptoms, and exercise capacity in adults with cyanotic congenital heart disease. J Am Coll Cardiol. 2006;48:356-365. doi: 10.1016/j.jacc.2006.03.040.
93. Roche SL, Redington AN. Right ventricle: wrong targets Another blow for pharmacotherapy in congenital heart diseases. Circulation. 2013;127:314-316. doi: 10.1161/CIRCULATIONAHA.112.155887.
94. Daliento L, Folino AF, Menti L, Zanco P, Baratella MC, Dalla Volta S. Adrenergic nervous activity in patients after surgical correction of tetralogy of Fallot. J Am Coll Cardiol. 2001;38:2043-2047.
95. Ohuchi H, Hasegawa S, Yasuda K, Yamada O, Ono Y, Echigo S. Severely impaired cardiac autonomic nervous activity after the Fontan operation Circulation. 2004;109:3257
96. Circulation. 2001;104:1513-1518.
97. Leuchte HH, Holzapfel M, Baumgartner RA, Ding I, Neurohr C, Vogeser M, Kolbe T, Schwaiblmair M, Behr J. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol. 2004;43:764-770. doi: 10.1016/j.jacc.2003.09.051.
98. Book WM. Heart failure in the adult patient with congenital heart disease. J Card Fail. 2005;11:306-312.
99. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
100. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709-717. doi: 10.1056/NEJM199909023411001.
101. Bristow MR. Beta-adrenergic receptor blockade in chronic heart failure. Circulation. 2000;101:558-569.
102. Packer M, Poole-Wilson PA, Armstrong PW, Cleland JG, Horowitz JD, Massie BM, Ryd L, Thygesen K, Uretsky BF. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure: ATLAS Study Group. Circulation. 1999;100:2312-2318.
103. Fowler MB. Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial: carvedilol in severe heart failure. Am J Cardiol. 2004;93:35B-39B. doi: 10.1016/j.amjcard.2004.01.004.
104. Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, Wikstrand J, El Allaf D, Vovec J, Aldershvile J, Halinen M, Dietz R, Neuhaus KL, Josi A, Thorgeirsson G, Dunselman PH, Gullestad L, Kuch J, Herlitz J, Rickenbacher P, Ball S, Gottlieb S, Deedwania P. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERITHF): MERIT-HF Study Group. JAMA. 2000;283:1295-1302.
105. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-13.
106. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure: U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349-1355. doi: 10.1056/NEJM199605233342101.
107. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shusterman N. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure: MOCHA Investigators. Circulation. 1996;94:2807-2816.
108. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database J Am Coll Cardiol. 2006;47:1502
109. J Am Coll Cardiol. 2006;47:76-84. doi: 10.1016/j.jacc.2005.09.022.
110. Lam CS, Lyass A, Kraigher-Krainer E, Massaro JM, Lee DS, Ho JE, Levy D, Redfield MM, Pieske BM, Benjamin EJ, Vasan RS. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community [published correction appears in Circulation. 2011;124:e458]. Circulation. 2011;124:24-30. doi: 10.1161/CIRCULATIONAHA.110.979203.
111. Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J; CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777-781. doi: 10.1016/S0140-6736(03)14285-7.
112. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, Anderson S, Donovan M, Iverson E, Staiger C, Ptaszynska A; I-PRESERVE Investigators. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359:2456-2467. doi: 10.1056/NEJMoa0805450.
113. Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J; PEP-CHF Investigators. The Perindopril in Elderly People With Chronic Heart Failure (PEP-CHF) study. Eur Heart J. 2006;27:2338-2345. doi: 10.1093/eurheartj/ehl250.
114. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, Mallis GI, Sollano JA, Shannon J, Tandon PK, DeMets DL; PROMISE Study Research Group. Effect of oral milrinone on mortality in severe chronic heart failure: the PROMISE Study Research Group. N Engl J Med. 1991;325:1468-1475. doi: 10.1056/NEJM199111213252103.
115. Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N, Marelli AJ. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679-1686. doi: 10.1161/CIRCULATIONAHA.109.866319.
116. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation. 2014;130:e270-e271
117. Circulation. 2014;130:2071-2104. doi: 10.1161/CIR.0000000000000040.
118. Hasselman T, Schneider D, Madan N, Jacobs M. Reversal of fenestration flow during ventricular systole in Fontan patients in junctional or ventricular paced rhythm. Pediatr Cardiol. 2005;26:638-641. doi: 10.1007/s00246-005-0879-6.
119. Dodge-Khatami A, Rahn M, Prre R, Bauersfeld U. Dual chamber epicardial pacing for the failing atriopulmonary Fontan patient. Ann Thorac Surg. 2005;80:1440-1444. doi: 10.1016/j.athoracsur.2005.03.128.
120. Barber BJ, Burch GH, Tripple D, Balaji S. Resolution of plastic bronchitis with atrial pacing in a patient with Fontan physiology. Pediatr Cardiol. 2004;25:73-76. doi: 10.1007/s00246-003-0529-9.
121. Silka MJ, Hardy BG, Menashe VD, Morris CD. A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol. 1998;32:245-251.
122. Kozak LJ, Owings MF, Hall MJ. National hospital discharge survey: 2002 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13.2005, 1-199
123. Atallah J, Erickson CC, Cecchin F, Dubin AM, Law IH, Cohen MI, Lapage MJ, Cannon BC, Chun TU, Freedenberg V, Gierdalski M, Berul CI; Pediatric and Congenital Electrophysiology Society (PACES). Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study. Circulation. 2013;127:2393-2402. doi: 10.1161/CIRCULATIONAHA.112.001120.
124. Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA, Viswanathan S, Chetaille P, Gordon E, Dore A, Cecchin F. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1:250-257. doi: 10.1161/CIRCEP.108.776120.
125. Khairy P, Harris L, Landzberg MJ, Viswanathan S, Barlow A, Gatzoulis MA, Fernandes SM, Beauchesne L, Therrien J, Chetaille P, Gordon E, Vonder Muhll I, Cecchin F. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation. 2008;117:363-370. doi: 10.1161/CIRCULATIONAHA.107.726372.
126. Yap SC, Roos-Hesselink JW, Hoendermis ES, Budts W, Vliegen HW, Mulder BJ, van Dijk AP, Schalij MJ, Drenthen W. Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. Eur Heart J. 2007;28:1854-1861. doi: 10.1093/eurheartj/ehl306.
127. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017. doi: 10.1056/NEJMoa071098.
128. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ; MADIT II Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51:1357-1365. doi: 10.1016/j.jacc.2007.09.073.
129. Khairy P, Mansour F. Implantable cardioverter-defibrillators in congenital heart disease: 10 programming tips. Heart Rhythm. 2011;8:480-483. doi: 10.1016/j.hrthm.2010.10.046.
130. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549. doi: 10.1056/NEJMoa050496.
131. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators. Cardiacresynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338. doi: 10.1056/NEJMoa0906431.
132. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL; Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-2395. doi: 10.1056/NEJMoa1009540.
133. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Circulation. 2009;120:e34-e35
134. Circulation. 2008;117:e350-e408. doi: 10.1161/CIRCUALTIONAHA.108.189742.
135. Cecchin F, Frangini PA, Brown DW, Fynn-Thompson F, Alexander ME, Triedman JK, Gauvreau K, Walsh EP, Berul CI. Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution. J Cardiovasc Electrophysiol. 2009;20:58-65. doi: 10.1111/j.1540-8167.2008.01274.x.
136. Dubin AM, Janousek J, Rhee E, Strieper MJ, Cecchin F, Law IH, Shannon KM, Temple J, Rosenthal E, Zimmerman FJ, Davis A, Karpawich PP, Al Ahmad A, Vetter VL, Kertesz NJ, Shah M, Snyder C, Stephenson E, Emmel M, Sanatani S, Kanter R, Batra A, Collins KK. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol. 2005;46:2277-2283. doi: 10.1016/j.jacc.2005.05.096.
137. Janousek J, Gebauer RA, Abdul-Khaliq H, Turner M, Kornyei L, Grollmuss O, Rosenthal E, Villain E, Fr A, Paul T, Blom NA, Happonen JM, Bauersfeld U, Jacobsen JR, van den Heuvel F, Delhaas T, Papagiannis J, Trigo C; Working Group for Cardiac Dysrhythmias and Electrophysiology of the Association for European Paediatric Cardiology. Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates. Heart. 2009;95:1165-1171. doi: 10.1136/hrt.2008.160465.
138. Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NA 3rd, Ferguson TB Jr, Hammill SC, Karasik PE, Link MS, Marine JE, Schoenfeld MH, Shanker AJ, Silka MJ, Stevenson LW, Stevenson WG, Varosy PD, Ellenbogen KA, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hayes DL, Page RL, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation. 2013;127:e357-e359
139. Circulation. 2012;126:1784-1800. doi: 10.1161/CIR.0b013e3182618569.
140. Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI, Daniels CJ, Deal BJ, Dearani JA, Groot Nd, Dubin AM, Harris L, Janousek J, Kanter RJ, Karpawich PP, Perry JC, Seslar SP, Shah MJ, Silka MJ, Triedman JK, Walsh EP, Warnes CA. PACES/HRS expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Heart Rhythm. 2014;11:e102-e165. doi: 10.1016/j.hrthm.2014.05.009.
141. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-e352. doi: 10.1161/CIR.0b013e318276ce9b.
142. Khairy P, Landzberg MJ, Gatzoulis MA, Mercier LA, Fernandes SM, CJM, Lavoie JP, Fournier A, Guerra PG, Frogoudaki A, Walsh EP, Dore A; Epicardial Versus ENdocardial pacing and Thromboembolic events Investigators. Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study. Circulation. 2006;113:2391-2397. doi: 10.1161/CIRCULATIONAHA.106.622076.
143. Tomaske M, Prre R, Rahn M, Bauersfeld U. Epicardial and pleural lead ICD systems in children and adolescents maintain functionality over 5 years. Europace. 2008;10:1152-1156. doi: 10.1093/europace/eun214.
144. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA. An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med. 2010;363:36-44. doi: 10.1056/NEJMoa0909545.
145. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, Alexander ME, Triedman JK, Walsh EP, Friedman RA. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685-1691. doi: 10.1016/j.jacc.2008.01.033.
146. Khairy P, Roux JF, Dubuc M, Thibault B, Guerra PG, Macle L, Mercier LA, Dore A, Roy D, Talajic M, PagP. Laser lead extraction in adult congenital heart disease. J Cardiovasc Electrophysiol. 2007;18:507-511. doi: 10.1111/j.1540-8167.2007.00782.x.
147. Kirjavainen M, Happonen JM, Louhimo I. Late results of Senning operation. J Thorac Cardiovasc Surg. 1999;117:488-495.
148. Puley G, Siu S, Connelly M, Harrison D, Webb G, Williams WG, Harris L. Arrhythmia and survival in patients >18 years of age after the Mustard procedure for complete transposition of the great arteries. Am J Cardiol. 1999;83:1080-1084.
149. Roos-Hesselink JW, Meijboom FJ, Spitaels SE, van Domburg R, van Rijen EH, Utens EM, McGhie J, Bos E, Bogers AJ, Simoons ML. Decline in ventricular function and clinical condition after Mustard repair for transposition of the great arteries (a prospective study of 22-29 years). Eur Heart J. 2004;25:1264-1270. doi: 10.1016/j.ehj.2004.03.009.
150. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL. Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol. 2000;36:255-261.
151. Bos JM, Hagler DJ, Silvilairat S, Cabalka A, O'Leary P, Daniels O, Miller FA, Abraham TP. Right ventricular function in asymptomatic individuals with a systemic right ventricle. J Am Soc Echocardiogr. 2006;19:1033-1037. doi: 10.1016/j.echo.2006.03.007.
152. Szymaski P, Klisiewicz A, Lubiszewska B, Lipczyska M, Michaek P, Janas J, Hoffman P. Application of classic heart failure definitions of asymptomatic and symptomatic ventricular dysfunction and heart failure symptoms with preserved ejection fraction to patients with systemic right ventricles. Am J Cardiol. 2009;104:414-418. doi: 10.1016/j. amjcard.2009.03.057.
153. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure, part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387-1393.
154. Derrick GP, Narang I, White PA, Kelleher A, Bush A, Penny DJ, Redington AN. Failure of stroke volume augmentation during exercise and dobutamine stress is unrelated to load-independent indexes of right ventricular performance after the Mustard operation. Circulation. 2000;102(suppl III):III154-III159.
155. Page E, Perrault H, Flore P, Rossignol AM, Pironneau S, Rocca C, Aguilaniu B. Cardiac output response to dynamic exercise after atrial switch repair for transposition of the great arteries. Am J Cardiol. 1996;77:892-895. doi: 10.1016/S0002-9149(97)89193-X.
156. Fratz S, Hager A, Busch R, Kaemmerer H, Schwaiger M, Lange R, Hess J, Stern HC. Patients after atrial switch operation for transposition of the great arteries can not increase stroke volume under dobutamine stress as opposed to patients with congenitally corrected transposition. Circ J. 2008;72:1130-1135.
157. Kammeraad JA, van Deurzen CH, Sreeram N, Bink-Boelkens MT, Ottenkamp J, Helbing WA, Lam J, Sobotka-Plojhar MA, Daniels O, Balaji S. Predictors of sudden cardiac death after Mustard or Senning repair for transposition of the great arteries. J Am Coll Cardiol. 2004;44:1095-1102. doi: 10.1016/j.jacc.2004.05.073.
158. Janousek J, Paul T, Luhmer I, Wilken M, Hruda J, Kallfelz HC. Atrial baffle procedures for complete transposition of the great arteries: natural course of sinus node dysfunction and risk factors for dysrhythmias and sudden death. Z Kardiol. 1994;83:933-938.
159. Gatzoulis MA, Walters J, McLaughlin PR, Merchant N, Webb GD, Liu P. Late arrhythmia in adults with the Mustard procedure for transposition of great arteries: a surrogate marker for right ventricular dysfunction Heart. 2000;84:409-415.
160. Salehian O, Schwerzmann M, Merchant N, Webb GD, Siu SC, Therrien J. Assessment of systemic right ventricular function in patients with transposition of the great arteries using the myocardial performance index: comparison with cardiac magnetic resonance imaging. Circulation. 2004;110:3229-3233. doi: 10.1161/01.CIR.0000147284.54140.73.
161. Moroseos T, Mitsumori L, Kerwin WS, Sahn DJ, Helbing WA, Kilner PJ, Shurman A, Litt H, Sheehan FH. Comparison of Simpson's method and three-dimensional reconstruction for measurement of right ventricular volume in patients with complete or corrected transposition of the great arteries. Am J Cardiol. 2010;105:1603-1609. doi: 10.1016/j. amjcard.2010.01.025.
162. Book WM, Hott BJ, McConnell M. B-type natriuretic peptide levels in adults with congenital heart disease and right ventricular failure. Am J Cardiol. 2005;95:545-546. doi: 10.1016/j.amjcard.2004.10.031.
163. Koch AM, Zink S, Singer H. B-type natriuretic peptide in patients with systemic right ventricle. Cardiology. 2008;110:1-7. doi: 10.1159/000109399.
164. Chow PC, Cheung EW, Chong CY, Lun KS, Yung TC, Wong KT, Chau AK, Cheung YF. Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation. Int J Cardiol. 2008;127:192-197. doi: 10.1016/j.ijcard.2007.06.004.
165. Giardini A, Lovato L, Donti A, Formigari R, Gargiulo G, Picchio FM, Fattori R. A pilot study on the effects of carvedilol on right ventricular remodelling and exercise tolerance in patients with systemic right ventricle. Int J Cardiol. 2007;114:241-246. doi: 10.1016/j.ijcard.2006.01.048.
166. Winter MM, Scherptong RW, Kumar S, Bouma BJ, Tulevski II, Tops LF, Roest AA, Vliegen HW, de Roos A, Groenink M, Mulder BJ. Ventricular response to stress predicts outcome in adult patients with a systemic right ventricle. Am Heart J. 2010;160:870-876. doi: 10.1016/j. ahj.2010.07.015.
167. Moons P, Gewillig M, Sluysmans T, Verhaaren H, Viart P, Massin M, Suys B, Budts W, Pasquet A, De Wolf D, Vliers A. Long term outcome up to 30 years after the Mustard or Senning operation: a nationwide multicentre study in Belgium. Heart. 2004;90:307-313.
168. Hechter SJ, Fredriksen PM, Liu P, Veldtman G, Merchant N, Freeman M, Therrien J, Benson L, Siu S, Webb G. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. Am J Cardiol. 2001;87:660-663, A11.
169. Robinson B, Heise CT, Moore JW, Anella J, Sokoloski M, Eshaghpour E. Afterload reduction therapy in patients following intraatrial baffle operation for transposition of the great arteries. Pediatr Cardiol. 2002;23:618-623. doi: 10.1007/s00246-002-0046-2.
170. Therrien J, Provost Y, Harrison J, Connelly M, Kaemmerer H, Webb GD. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. Int J Cardiol. 2008;129:187-192. doi: 10.1016/j.ijcard.2008.04.056.
171. Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, Barker PC, Ravishankar C, McCrindle BW, Williams RV, Altmann K, Ghanayem NS, Margossian R, Chung WK, Border WL, Pearson GD, Stylianou MP, Mital S; Pediatric Heart Network Investigators. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010;122:333-340. doi: 10.1161/CIRCULATIONAHA.109.927988.
172. Anderson PA, Breitbart RE, McCrindle BW, Sleeper LA, Atz AM, Hsu DT, Lu M, Margossian R, Williams RV. The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers. Pediatr Cardiol. 2010;31:1219-1228. doi: 10.1007/s00246-010-9807-5.
173. Lester SJ, McElhinney DB, Viloria E, Reddy GP, Ryan E, Tworetzky W, Schiller NB, Foster E. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. Am J Cardiol. 2001;88:1314-1316.
174. Dore A, Houde C, Chan KL, Ducharme A, Khairy P, Juneau M, Marcotte F, Mercier LA. Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial. Circulation. 2005;112:2411-2416. doi: 10.1161/CIRCULATIONAHA.105.543470.
175. van der Bom T, Winter MM, Bouma BJ, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ. Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial. Circulation. 2013;127:322-330. doi: 10.1161/CIRCULATIONAHA.112.135392.
176. Josephson CB, Howlett JG, Jackson SD, Finley J, Kells CM. A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of beta-blockade. Can J Cardiol. 2006;22:769-772.
177. Doughan AR, McConnell ME, Book WM. Effect of beta blockers (carvedilol or metoprolol XL) in patients with transposition of great arteries and dysfunction of the systemic right ventricle. Am J Cardiol. 2007;99:704-706. doi: 10.1016/j.amjcard.2006.10.025.
178. Lindenfeld J, Keller K, Campbell DN, Wolfe RR, Quaife RA. Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. J Heart Lung Transplant. 2003;22:198-201.
179. Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY; Pediatric Carvedilol Study Group. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171-1179. doi: 10.1001/jama.298.10.1171.
180. Ishibashi N, Park IS, Waragai T, Yoshikawa T, Murakami Y, Mori K, Mimori S, Ando M, Takahashi Y, Doi S, Mizutani S, Nakanishi T. Effect of carvedilol on heart failure in patients with a functionally univentricular heart. Circ J. 2011;75:1394-1399.
181. Janousek J. Electrical resychronization of failing right ventricle. Circulation. 2004;109:e5; author reply e5. doi: 10.1161/01.CIR. 0000111125.72039.83.
182. Van de Veire NR, Blom NA, Holman ER, Schalij MJ, Bax JJ. Triplane tissue Doppler imaging to evaluate mechanical dyssynchrony before and after cardiac resynchronization in a patient with congenitally corrected transposition of the great arteries. J Cardiovasc Electrophysiol. 2007;18:222-225.
183. Jauvert G, Rousseau-Paziaud J, Villain E, Iserin L, Hidden-Lucet F, Ladouceur M, Sidi D. Effects of cardiac resynchronization therapy on echocardiographic indices, functional capacity, and clinical outcomes of patients with a systemic right ventricle. Europace. 2009;11:184-190. doi: 10.1093/europace/eun319.
184. Janousek J, Tomek V, Chaloupeck VA, Reich O, Gebauer RA, Kautzner J, Huc B. Cardiac resynchronization therapy: a novel adjunct to the treatment and prevention of systemic right ventricular failure. J Am Coll Cardiol. 2004;44:1927-1931. doi: 10.1016/j.jacc.2004.08.044.
185. Bottega NA, Kapa S, Edwards WD, Connolly HM, Munger TM, Warnes CA, Asirvatham SJ. The cardiac veins in congenitally corrected transposition of the great arteries: delivery options for cardiac devices. Heart Rhythm. 2009;6:1450-1456. doi: 10.1016/j.hrthm.2009.07.037.
186. Uemura H, Ho SY, Anderson RH, Gerlis LM, Devine WA, Neches WH, Yagihara T, Kawashima Y. Surgical anatomy of the coronary circulation in hearts with discordant atrioventricular connections. Eur J Cardiothorac Surg. 1996;10:194-200.
187. Chakrabarti S, Szantho G, Turner MS, Stuart G, Martin RP. Use of radiofrequency perforation for lead placement in biventricular or conventional endocardial pacing after mustard or senning operations for D-transposition of the great arteries. Pacing Clin Electrophysiol. 2009;32:1123-1129. doi: 10.1111/j.1540-8159.2009.02453.x.
188. Kiesewetter C, Michael K, Morgan J, Veldtman GR. Left ventricular dysfunction after cardiac resynchronization therapy in congenital heart disease patients with a failing systemic right ventricle. Pacing Clin Electrophysiol. 2008;31:159-162. doi: 10.1111/j.1540-8159.2007.00963.x.
189. Bonow RO, Carabello BA, Kanu C, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease). Circulation. 2006;114:e84-e231.
190. Circulation. 2007;115:e409
191. Circulation. 2010;121:e443
192. Joyce DL, Crow SS, John R, St. Louis JD, Braunlin EA, Pyles LA, Kofflin P, Joyce LD. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant. 2010;29:1302-1305. doi: 10.1016/j.healun.2010.05.030.
193. Jouan J, Grinda JM, Bricourt MO, Iserin L, Fabiani JN. Non-pulsatile axial flow ventricular assist device for right systemic ventricle failure late after Senning procedure. Int J Artif Organs. 2009;32:243-245.
194. Sugiura T, Kurosawa H, Shin'oka T, Kawai A. Successful explantation of ventricular assist device for systemic ventricular assistance in a patient with congenitally corrected transposition of the great arteries. Interact Cardiovasc Thorac Surg. 2006;5:792-793. doi: 10.1510/icvts.2006.139337.
195. Fishberger SB, Asnes JD, Rollinson NL, Cleman MW. Percutaneous right ventricular support during catheter ablation of intra-atrial reentrant tachycardia in an adult with a mustard baffle: a novel use of the Impella device. J Interv Card Electrophysiol. 2010;29:69-72. doi: 10.1007/s10840-010-9478-4.
196. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM; HeartWare Investigators. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol. 2011;57:1375-1382. doi: 10.1016/j.jacc.2010.10.040.
197. Huebler M, Stepanenko A, Krabatsch T, Potapov EV, Hetzer R. Mechanical circulatory support of systemic ventricle in adults with transposition of great arteries. ASAIO J. 2012;58:12-14. doi: 10.1097/MAT.0b013e31823a82df.
198. Jacobs S, Rega F, Burkhoff D, Meyns B. The use of a CircuLite micropump for congenitally corrected transposition of the great arteries. Eur J Cardiothorac Surg. 2012;42:741-743. doi: 10.1093/ejcts/ezs308.
199. Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26:240-248.
200. Williams DB, Kiernan PD, Metke MP, Marsh HM, Danielson GK. Hemodynamic response to positive end-expiratory pressure following right atrium-pulmonary artery bypass (Fontan procedure). J Thorac Cardiovasc Surg. 1984;87:856-861.
201. Bridges ND, Lock JE, Castaneda AR. Baffle fenestration with subsequent transcatheter closure: modification of the Fontan operation for patients at increased risk. Circulation. 1990;82:1681-1689.
202. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the Fontan operation: an international multicenter study: PLE Study Group. J Thorac Cardiovasc Surg. 1998;115:1063-1073.
203. Griffiths ER, Kaza AK, Wyler von Ballmoos MC, Loyola H, Valente AM, Blume ED, del Nido P. Evaluating failing Fontans for heart transplantation: predictors of death. Ann Thorac Surg. 2009;88:558-563. doi: 10.1016/j.athoracsur.2009.03.085.
204. Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP, Cope R, Sheron N, Millward-Sadler H, Veldtman GR, Iredale JP. Hepatic fibrosis and cirrhosis in the Fontan circulation: a detailed morphological study. J Clin Pathol. 2008;61:504-508. doi: 10.1136/jcp.2007.052365.
205. Friedrich-Rust M, Koch C, Rentzsch A, Sarrazin C, Schwarz P, Herrmann E, Lindinger A, Sarrazin U, Poynard T, Schers HJ, Zeuzem S, Abdul-Khaliq H. Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers. J Thorac Cardiovasc Surg. 2008;135:560-567. doi: 10.1016/j. jtcvs.2007.09.039.
206. Camposilvan S, Milanesi O, Stellin G, Pettenazzo A, Zancan L, D'Antiga L. Liver and cardiac function in the long term after Fontan operation. Ann Thorac Surg. 2008;86:177-182. doi: 10.1016/j.athoracsur.2008.03.077.
207. Baek JS, Bae EJ, Ko JS, Kim GB, Kwon BS, Lee SY, Noh CI, Park EA, Lee W. Late hepatic complications after Fontan operation; non-invasive markers of hepatic fibrosis and risk factors. Heart. 2010;96:1750-1755. doi: 10.1136/hrt.2010.201772.
208. Guha IN, Bokhandi S, Ahmad Z, Sheron N, Cope R, Marshall C, Veldtman G. Structural and functional uncoupling of liver performance in the Fontan circulation. Int J Cardiol. 2013;164:77-81. doi: 10.1016/j. ijcard.2011.06.062.
209. Schwartz MC, Sullivan L, Cohen MS, Russo P, John AS, Guo R, Guttenberg M, Rand EB. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: an autopsy study. J Thorac Cardiovasc Surg. 2012;143:904-909. doi: 10.1016/j.jtcvs.2011.08.038.
210. Furukawa T, Akimoto K, Ohtsuki M, Sato K, Suzuki M, Takahashi K, Kishiro M, Shimizu T, Kawasaki S. Non-invasive assessment of liver fibrosis in patients after the Fontan operation. Pediatr Int. 2011;53:980-984. doi: 10.1111/j.1442-200X.2011.03497.x.
211. Ginde S, Hohenwalter MD, Foley WD, Sowinski J, Bartz PJ, Venkatapuram S, Weinberg C, Tweddell JS, Earing MG. Noninvasive assessment of liver fibrosis in adult patients following the Fontan procedure. Congenit Heart Dis. 2012;7:235-242. doi: 10.1111/j.1747-0803.2012.00632.x.
212. Rychik J, Veldtman G, Rand E, Russo P, Rome JJ, Krok K, Goldberg DJ, Cahill AM, Wells RG. The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol. 2012;33:1001-1012. doi: 10.1007/s00246-012-0315-7.
213. Krieger EV, Moko LE, Wu F, Landzberg MJ, Valente AM, Assenza GE, Ukomadu C, Opotowsky AR. Single ventricle anatomy is associated with increased frequency of nonalcoholic cirrhosis. Int J Cardiol. 2013;167:1918-1923. doi: 10.1016/j.ijcard.2012.05.002.
214. McCabe N, Farris AB, Hon H, Ford R, Book WM. Hepatocellular carcinoma in an adult with repaired tetralogy of Fallot. Congenit Heart Dis. 2013;8:E139-E144. doi: 10.1111/j.1747-0803.2012.00700.x.
215. Wallihan DB, Podberesky DJ. Hepatic pathology after Fontan palliation: spectrum of imaging findings. Pediatr Radiol. 2013;43:330-338. doi: 10.1007/s00247-012-2531-y.
216. Johnson JA, Cetta F, Graham RP, Smyrk TC, Driscoll DJ, Phillips SD, John AS. Identifying predictors of hepatic disease in patients after the Fontan operation: a postmortem analysis. J Thorac Cardiovasc Surg. 2013;146:140-145. doi: 10.1016/j.jtcvs.2012.09.005.
217. Assenza GE, Graham DA, Landzberg MJ, Valente AM, Singh MN, Bashir A, Fernandes S, Mortele KJ, Ukomadu C, Volpe M, Wu F. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery. Heart. 2013;99:491-496. doi: 10.1136/heartjnl-2012-303347.
218. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med. 2013;368:1756-1757. doi: 10.1056/NEJMc1214222.
219. Elder RW, McCabe NM, Hebson C, Veledar E, Romero R, Ford RM, Mahle WT, Kogon BE, Sahu A, Jokhadar M, McConnell ME, Book WM. Features of portal hypertension are associated with major adverse events in Fontan patients: the VAST study. Int J Cardiol. 2013;168:3764-3769. doi: 10.1016/j.ijcard.2013.06.008.
220. Kutty SS, Peng Q, Danford DA, Fletcher SE, Perry D, Talmon GA, Scott C, Kugler JD, Duncan KF, Quiros-Tejeira RE, Kutty S; Liver Adult-Pediatric-Congenital-Heart-Disease Dysfunction Study (LADS) Group. Increased hepatic stiffness as consequence of high hepatic afterload in the Fontan circulation: a vascular Doppler and elastography study. Hepatology. 2014;59:251-260. doi: 10.1002/hep.26631.
221. Vonder Muhll I, Liu P, Webb G. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease. Int J Cardiol. 2004;97(suppl 1):25-33. doi: 10.1016/j.ijcard.2004.08.006.
222. Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J. 2008;29:1681-1687. doi: 10.1093/eurheartj/ehn215.
223. Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W. Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging. 2014;7:265-273.
224. Goldberg DJ, French B, Szwast AL, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J. Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation. Pediatr Cardiol. 2012;33:689-696. doi: 10.1007/s00246-012-0196-9.
225. Shabanian R, Shahbaznejad L, Razaghian A, Kiani A, Rahimzadeh M, Seifirad S, Kocharian A, Gilani JS, Navabi MA. Sildenafil and ventriculo-arterial coupling in Fontan-palliated patients: a noninvasive echocardiographic assessment. Pediatr Cardiol. 2013;34:129-134. doi: 10.1007/s00246-012-0400-y.
226. Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J. Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation. 2011;123:1185-1193. doi: 10.1161/CIRCULATIONAHA.110.981746.
227. Bowater SE, Weaver RA, Thorne SA, Clift PF. The safety and effects of bosentan in patients with a Fontan circulation. Congenit Heart Dis. 2012;7:243-249. doi: 10.1111/j.1747-0803.2012.00635.x.
228. Ovaert C, Thijs D, Dewolf D, Ottenkamp J, Dessy H, Moons P, Gewillig M, Mertens L. The effect of bosentan in patients with a failing Fontan circulation. Cardiol Young. 2009;19:331-339. doi: 10.1017/S1047951109990023.
229. Schuuring MJ, Vis JC, van Dijk AP, van Melle JP, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ. Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail. 2013;15:690-698. doi: 10.1093/eurjhf/hft017.
230. Hebert A, Jensen AS, Idorn L, Sensen KE, Sdergaard L. The effect of bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study. BMC Cardiovasc Disord. 2013;13:36. doi: 10.1186/1471-2261-13-36.
231. Koide M, Carabello BA, Conrad CC, Buckley JM, DeFreyte G, Barnes M, Tomanek RJ, Wei CC, Dell'Italia LJ, Cooper G 4th, Zile MR. Hypertrophic response to hemodynamic overload: role of load vs. reninangiotensin system activation. Am J Physiol. 1999;276(pt 2):H350-H358.
232. Bacha EA, Zimmerman FJ, Mor-Avi V, Weinert L, Starr JP, Sugeng L, Lang RM. Ventricular resynchronization by multisite pacing improves myocardial performance in the postoperative single-ventricle patient. Ann Thorac Surg. 2004;78:1678-1683. doi: 10.1016/j. athoracsur.2004.04.065.
233. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published correction appears in Circulation. 2014;129:e650]. Circulation. 2014;129:2440-2492. doi: 10.1161/CIR.0000000000000029.
234. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published corrections appear in Circulation. 2014;130:e120 and Circulation. 2014;129:e651]. Circulation. 2014;129:e521-e643. doi: 10.1161/CIR.0000000000000031.
235. McCrindle BW. Independent predictors of immediate results of percutaneous balloon aortic valvotomy in children: Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Am J Cardiol. 1996;77:286-293.
236. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success. J Am Coll Cardiol. 1996;27:1257-1263. doi: 10.1016/0735-1097(95)00608-7.
237. Moltzer E, Mattace Raso FU, Karamermer Y, Boersma E, Webb GD, Simoons ML, Danser AH, van den Meiracker AH, Roos-Hesselink JW. Comparison of Candesartan versus Metoprolol for treatment of systemic hypertension after repaired aortic coarctation. Am J Cardiol. 2010;105:217-222. doi: 10.1016/j.amjcard.2009.08.674.
238. Emani SM, Bacha EA, McElhinney DB, Marx GR, Tworetzky W, Pigula FA, del Nido PJ. Primary left ventricular rehabilitation is effective in maintaining two-ventricle physiology in the borderline left heart. J Thorac Cardiovasc Surg. 2009;138:1276-1282. doi: 10.1016/j.jtcvs.2009.08.009.
239. Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN. Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation. Br Heart J. 1992;67:470-473.
240. Dave HH, Buechel ER, Dodge-Khatami A, Kadner A, Rousson V, Bauersfeld U, Prre R. Early insertion of a pulmonary valve for chronic regurgitation helps restoration of ventricular dimensions. Ann Thorac Surg. 2005;80:1615-1620. doi: 10.1016/j.athoracsur.2005.04.058.
241. Gengsakul A, Harris L, Bradley TJ, Webb GD, Williams WG, Siu SC, Merchant N, McCrindle BW. The impact of pulmonary valve replacement after tetralogy of Fallot repair: a matched comparison. Eur J Cardiothorac Surg. 2007;32:462-468. doi: 10.1016/j.ejcts.2007.06.009.
242. Harrild DM, Berul CI, Cecchin F, Geva T, Gauvreau K, Pigula F, Walsh EP. Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia. Circulation. 2009;119:445-451. doi: 10.1161/CIRCULATIONAHA.108.775221.
243. Karamlou T, McCrindle BW, Williams WG. Surgery insight: late complications following repair of tetralogy of Fallot and related surgical strategies for management. Nat Clin Pract Cardiovasc Med. 2006;3:611-622. doi: 10.1038/ncpcardio0682.
244. Rowe SA, Zahka KG, Manolio TA, Horneffer PJ, Kidd L. Lung function and pulmonary regurgitation limit exercise capacity in postoperative tetralogy of Fallot. J Am Coll Cardiol. 1991;17:461-466.
245. Scherptong RW, Hazekamp MG, Mulder BJ, Wijers O, Swenne CA, van der Wall EE, Schalij MJ, Vliegen HW. Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome. J Am Coll Cardiol. 2010;56:1486-1492. doi: 10.1016/j.jacc.2010.04.058.
246. Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JC, Smith GC, Tat T, Pennell DJ, Gatzoulis MA. Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction. J Am Coll Cardiol. 2002;40:2044-2052.
247. Coats L, Khambadkone S, Derrick G, Sridharan S, Schievano S, Mist B, Jones R, Deanfield JE, Pellerin D, Bonhoeffer P, Taylor AM. Physiological and clinical consequences of relief of right ventricular outflow tract obstruction late after repair of congenital heart defects. Circulation. 2006;113:2037-2044. doi: 10.1161/CIRCULATIONAHA.105.591438.
248. Romeih S, Kroft LJ, Bokenkamp R, Schalij MJ, Grotenhuis H, Hazekamp MG, Groenink M, de Roos A, Blom NA. Delayed improvement of right ventricular diastolic function and regression of right ventricular mass after percutaneous pulmonary valve implantation in patients with congenital heart disease. Am Heart J. 2009;158:40-46. doi: 10.1016/j.ahj.2009.04.023.
249. Uebing A, Gibson DG, Babu-Narayan SV, Diller GP, Dimopoulos K, Goktekin O, Spence MS, Andersen K, Henein MY, Gatzoulis MA, Li W. Right ventricular mechanics and QRS duration in patients with repaired tetralogy of Fallot: implications of infundibular disease. Circulation. 2007;116:1532-1539. doi: 10.1161/CIRCULATIONAHA.107.688770.
250. Gatzoulis MA, Sheppard MN, Ho SY. Value and impact of necropsy in paediatric cardiology. Heart. 1996;75:626-631.
251. Helbing WA, Niezen RA, Le Cessie S, van der Geest RJ, Ottenkamp J, de Roos A. Right ventricular diastolic function in children with pulmonary regurgitation after repair of tetralogy of Fallot: volumetric evaluation by magnetic resonance velocity mapping. J Am Coll Cardiol. 1996;28:1827-1835. doi: 10.1016/S0735-1097(96)00387-7.
252. Apitz C, Latus H, Binder W, Uebing A, Seeger A, Bretschneider C, Sieverding L, Hofbeck M. Impact of restrictive physiology on intrinsic diastolic right ventricular function and lusitropy in children and adolescents after repair of tetralogy of Fallot. Heart. 2010;96:1837-1841. doi: 10.1136/hrt.2010.203190.
253. Chaturvedi RR, Shore DF, Lincoln C, Mumby S, Kemp M, Brierly J, Petros A, Gutteridge JM, Hooper J, Redington AN. Acute right ventricular restrictive physiology after repair of tetralogy of Fallot: association with myocardial injury and oxidative stress. Circulation. 1999;100:1540-1547.
254. Babu-Narayan SV, Uebing A, Davlouros PA, Kemp M, Davidson S, Dimopoulos K, Bayne S, Pennell DJ, Gibson DG, Flather M, Kilner PJ, Li W, Gatzoulis MA. Randomised trial of ramipril in repaired tetralogy of Fallot and pulmonary regurgitation: the APPROPRIATE study (Ace inhibitors for Potential PRevention Of the deleterious effects of Pulmonary Regurgitation In Adults with repaired TEtralogy of Fallot). Int J Cardiol. 2012;154:299-305. doi: 10.1016/j.ijcard.2010.09.057.
255. Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, Li Z, Hodge DO, Driscoll DJ. Effect of operation for Ebstein anomaly on left ventricular function. Am J Cardiol. 2008;102:1724-1727. doi: 10.1016/j.amjcard.2008.08.018.
256. Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol. 2004;43:1068-1074. doi: 10.1016/j.jacc.2003.10.045.
257. Celermajer DS, Dodd SM, Greenwald SE, Wyse RK, Deanfield JE. Morbid anatomy in neonates with Ebstein's anomaly of the tricuspid valve: pathophysiologic and clinical implications. J Am Coll Cardiol. 1992;19:1049-1053.
258. Davos CH, Davlouros PA, Wensel R, Francis D, Davies LC, Kilner PJ, Coats AJ, Piepoli M, Gatzoulis MA. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation. 2002;106(suppl 1):I69-I75.
259. Norozi K, Bahlmann J, Raab B, Alpers V, Arnhold JO, Kuehne T, Klimes K, Zoege M, Geyer S, Wessel A, Buchhorn R. A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot. Cardiol Young. 2007;17:372-379. doi: 10.1017/S1047951107000844.
260. Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, McGoon DC, Kirklin JW, Danielson GK. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993;329:593-599. doi: 10.1056/NEJM199308263290901.
261. Nollert G, Fischlein T, Bouterwek S, Bmer C, Klinner W, Reichart B. Long-term survival in patients with repair of tetralogy of Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol. 1997;30:1374-1383.
262. Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, Rosenthal M, Nakazawa M, Moller JH, Gillette PC, Webb GD, Redington AN. Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981. doi: 10.1016/S0140-6736(00)02714-8.
263. Knauth AL, Gauvreau K, Powell AJ, Landzberg MJ, Walsh EP, Lock JE, del Nido PJ, Geva T. Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair. Heart. 2008;94:211-216. doi: 10.1136/hrt.2006.104745.
264. Ghai A, Silversides C, Harris L, Webb GD, Siu SC, Therrien J. Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol. 2002;40:1675-1680.
265. Khairy P, Landzberg MJ, Gatzoulis MA, Lucron H, Lambert J, Marn F, Alexander ME, Walsh EP. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994-2000. doi: 10.1161/01.CIR.0000126495.11040.BD.
266. Van der Hulst AE, Delgado V, Blom NA, van de Veire NR, Schalij MJ, Bax JJ, Roest AA, Holman ER. Cardiac resynchronization therapy in paediatric and congenital heart disease patients. Eur Heart J. 2011;32:2236-2246. doi: 10.1093/eurheartj/ehr093.
267. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation. 2003;107:2287-2289. doi: 10.1161/01. CIR.0000070930.33499.9F.
268. Thambo JB, Dos Santos P, De Guillebon M, Roubertie F, Labrousse L, Sacher F, Iriart X, Lafitte S, Ploux S, Jais P, Roques X, Haissaguerre M, Ritter P, Clementy J, Narayan SM, Bordachar P. Biventricular stimulation improves right and left ventricular function after tetralogy of Fallot repair: acute animal and clinical studies. Heart Rhythm. 2010;7:344-350. doi: 10.1016/j.hrthm.2009.11.019.
269. Kirsh JA, Stephenson EA, Redington AN. Images in cardiovascular medicine. Recovery of left ventricular systolic function after biventricular resynchronization pacing in a child with repaired tetralogy of Fallot and severe biventricular dysfunction. Circulation. 2006;113:e691-e692. doi: 10.1161/CIRCULATIONAHA.105.580126.
270. Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, Bullock EA, Kfoury AG, Yetman AT. Would access to device therapies improve transplant outcomes for adults with congenital heart disease Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011;30:395-401. doi: 10.1016/j.healun.2010.09.008.
271. Karamlou T, Hirsch J, Welke K, Ohye RG, Bove EL, Devaney EJ, Gajarski RJ. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010;140:161-168. doi: 10.1016/j.jtcvs.2010.03.036.
272. Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. J Heart Lung Transplant. 2013;32:1059-1064. doi: 10.1016/j.healun.2013.06.024.
273. Haddad H, Isaac D, Legare JF, Pflugfelder P, Hendry P, Chan M, Cantin B, Giannetti N, Zieroth S, White M, Warnica W, Doucette K, Rao V, Dipchand A, Cantarovich M, Kostuk W, Cecere R, Charbonneau E, Ross H, Poirier N. Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: executive summary. Can J Cardiol. 2009;25:197-205.
274. Ross H, Tinckam K, Rao V, West LJ. In praise of ventricular assist devices: mechanical bridge to virtual crossmatch for the sensitized patient. J Heart Lung Transplant. 2010;29:728-730. doi: 10.1016/j.healun.2010.02.006.
275. Kirk R, Dipchand AI, Edwards LB, Kucheryavaya AY, Benden C, Christie JD, Dobbles F, Rahmel AO, Stehlik J, Hertz MI; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation report-2012. J Heart Lung Transplant. 2012;31:1065-1072. doi: 10.1016/j.healun.2012.08.001.
276. Inuzuka R, Diller GP, Borgia F, Benson L, Tay EL, Alonso-Gonzalez R, Silva M, Charalambides M, Swan L, Dimopoulos K, Gatzoulis MA. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation. 2012;125:250-259. doi: 10.1161/CIRCULATIONAHA.111.058719.
277. Fernandes SM, Alexander ME, Graham DA, Khairy P, Clair M, Rodriguez E, Pearson DD, Landzberg MJ, Rhodes J. Exercise testing identifies patients at increased risk for morbidity and mortality following Fontan surgery. Congenit Heart Dis. 2011;6:294-303. doi: 10.1111/j.1747-0803.2011.00500.x.
278. Radojevic J, Inuzuka R, Alonso-Gonzalez R, Borgia F, Giannakoulas G, Prapa M, Liodakis E, Li W, Swan L, Diller GP, Dimopoulos K, Gatzoulis MA. Peak oxygen uptake correlates with disease severity and predicts outcome in adult patients with Ebstein's anomaly of the tricuspid valve. Int J Cardiol. 2013;163:305-308. doi: 10.1016/j.ijcard.2011.06.047.
279. Giardini A, Hager A, Lammers AE, Derrick G, Mler J, Diller GP, Dimopoulos K, Odendaal D, Gargiulo G, Picchio FM, Gatzoulis MA. Ventilatory efficiency and aerobic capacity predict event-free survival in adults with atrial repair for complete transposition of the great arteries. J Am Coll Cardiol. 2009;53:1548-1555. doi: 10.1016/j.jacc.2009.02.005.
280. Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123:759-767. doi: 10.1161/CIRCULATIONAHA.110.960260.
281. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. J Heart Lung Transplant. 2006;25:1024-1042. doi: 10.1016/j.healun.2006.06.008.
282. Nwakanma LU, Williams JA, Weiss ES, Russell SD, Baumgartner WA, Conte JV. Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. Ann Thorac Surg. 2007;84:1556-1562. doi: 10.1016/j.athoracsur.2007.05.095.
283. Meyer SR, Campbell PM, Rutledge JM, Halpin AM, Hawkins LE, Lakey JR, Rebeyka IM, Ross DB. Use of an allograft patch in repair of hypoplastic left heart syndrome may complicate future transplantation. Eur J Cardiothorac Surg. 2005;27:554-560. doi: 10.1016/j.ejcts.2004.12.033.
284. Feingold B, Park SY, Comer DM, Bryce CL, Webber SA. Listing requirements for a prospective crossmatch in pediatric heart transplantation: analysis of Organ Procurement and Transplantation Network data from 1996 to 2009. J Heart Lung Transplant. 2012;31:1143-1144. doi: 10.1016/j.healun.2012.08.006.
285. Kfoury AG, Stehlik J, Renlund DG, Snow G, Seaman JT, Gilbert EM, Stringham JS, Long JW, Hammond ME. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns. J Heart Lung Transplant. 2006;25:1277-1282. doi: 10.1016/j.healun.2006.08.009.
286. Wu GW, Kobashigawa JA, Fishbein MC, Patel JK, Kittleson MM, Reed EF, Kiyosaki KK, Ardehali A. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes. J Heart Lung Transplant. 2009;28:417-422. doi: 10.1016/j.healun.2009.01.015.
287. Stastny P, Lavingia B, Fixler DE, Yancy CW, Ring WS. Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation. 2007;84:738-745. doi: 10.1097/01.tp.0000281918.51138.3f.
288. Tambur AR, Pamboukian SV, Costanzo MR, Herrera ND, Dunlap S, Montpetit M, Heroux A. The presence of HLA-directed antibodies after heart transplantation is associated with poor allograft outcome. Transplantation. 2005;80:1019-1025.
289. Smith RN, Ueno T, Ito T, Tanaka K, Shea SP, Abdi R. Chemokines and chronic heart allograft rejection. Transplantation. 2007;84:442-444. doi: 10.1097/01.tp.0000277535.02541.30.
290. Patel ND, Weiss ES, Allen JG, Russell SD, Shah AS, Vricella LA, Conte JV. Heart transplantation for adults with congenital heart disease: analysis of the United Network For Organ Sharing database. Ann Thorac Surg. 2009;88:814-821. doi: 10.1016/j.athoracsur.2009.04.071.
291. Chen JM, Davies RR, Mital SR, Mercando ML, Addonizio LJ, Pinney SP, Hsu DT, Lamour JM, Quaegebeur JM, Mosca RS. Trends and outcomes in transplantation for complex congenital heart disease: 1984 to 2004. Ann Thorac Surg. 2004;78:1352-1361. doi: 10.1016/j. athoracsur.2004.04.012.
292. Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT. Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992. Am J Cardiol. 2007;100:1307-1309. doi: 10.1016/j.amjcard.2007.05.059.
293. Waddell TK, Bennett L, Kennedy R, Todd TR, Keshavjee SH. Heartlung or lung transplantation for Eisenmenger syndrome. J Heart Lung Transplant. 2002;21:731-737.
294. Deleted in proof.
295. Canter CE, Shaddy RE, Bernstein D, Hsu DT, Chrisant MR, Kirklin JK, Kanter KR, Higgins RS, Blume ED, Rosenthal DN, Boucek MM, Uzark KC, Friedman AH, Friedman AH, Young JK. Indications for heart transplantation in pediatric heart disease: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group [published correction appears in Circulation. 2007;115:e385]. Circulation. 2007;115:658-676. doi: 10.1161/CIRCULATIONAHA.106.180449.
296. Michielon G, Parisi F, Squitieri C, Carotti A, Gagliardi G, Pasquini L, Di Donato RM. Orthotopic heart transplantation for congenital heart disease: An alternative for high-risk fontan candidates Circulation. 2003;108(suppl 1):II140-149.
297. Chrisant MR, Naftel DC, Drummond-Webb J, Chinnock R, Canter CE, Boucek MM, Boucek RJ, Hallowell SC, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study Group. Fate of infants with hypoplastic left heart syndrome listed for cardiac transplantation: a multicenter study. J Heart Lung Transplant. 2005;24:576-582. doi: 10.1016/j.healun.2004.01.019.
298. Jacobs JP, Quintessenza JA, Chai PJ, Lindberg HL, Asante-Korang A, McCormack J, Dadlani G, Boucek RJ. Rescue cardiac transplantation for failing staged palliation in patients with hypoplastic left heart syndrome. Cardiol Young. 2006;16:556-562. doi: 10.1017/S1047951106001223.
299. McHugh KE, Hillman DG, Gurka MJ, Gutgesell HP. Three-stage palliation of hypoplastic left heart syndrome in the University HealthSystem Consortium. Congenit Heart Dis. 2010;5:8-15. doi: 10.1111/j.1747-0803.2009.00367.x.
300. Ashburn DA, McCrindle BW, Tchervenkov CI, Jacobs ML, Lofland GK, Bove EL, Spray TL, Williams WG, Blackstone EH. Outcomes after the Norwood operation in neonates with critical aortic stenosis or aortic valve atresia. J Thorac Cardiovasc Surg. 2003;125:1070-1082. doi: 10.1067/mtc.2003.183.
301. Bernstein D, Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, Hsu D, Canter CE, Kirklin JK, Morrow WR; Pediatric Heart Transplant Study. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114:273-280. doi: 10.1161/CIRCULATIONAHA.105.548016.
302. Petko M, Myung RJ, Wernovsky G, Cohen MI, Rychik J, Nicolson SC, Gaynor JW, Spray TL. Surgical reinterventions following the Fontan procedure. Eur J Cardiothorac Surg. 2003;24:255-259.
303. Carey JA, Hamilton JR, Hilton CJ, Dark JH, Forty J, Parry G, Hasan A. Orthotopic cardiac transplantation for the failing Fontan circulation. Eur J Cardiothorac Surg. 1998;14:7-13.
304. Gossett JG, Almond CS, Kirk R, Zangwill S, Richmond ME, Kantor PF, Tresler MA, Lenderman SM, Naftel DC, Matthews KL, Pahl E. Outcomes of cardiac transplantation in single-ventricle patients with plastic bronchitis: a multicenter study. J Am Coll Cardiol. 2013;61:985-986. doi: 10.1016/j.jacc.2012.10.042.
305. Ekman Joelsson BM, Sunnegdh J, Hanseus K, Berggren H, Jonzon A, Ji P, Lundell B. The outcome of children born with pulmonary atresia and intact ventricular septum in Sweden from 1980 to 1999. Scand Cardiovasc J. 2001;35:192-198.
306. Bull C, Kostelka M, Sorensen K, de Leval M. Outcome measures for the neonatal management of pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1994;107:359-366.
307. Ashburn DA, Blackstone EH, Wells WJ, Jonas RA, Pigula FA, Manning PB, Lofland GK, Williams WG, McCrindle BW; Congenital Heart Surgeons Study Members. Determinants of mortality and type of repair in neonates with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg. 2004;127:1000-1007. doi: 10.1016/j.jtcvs.2003.11.057.
308. Guleserian KJ, Armsby LB, Thiagarajan RR, del Nido PJ, Mayer JE Jr. Natural history of pulmonary atresia with intact ventricular septum and right-ventricle-dependent coronary circulation managed by the single-ventricle approach. Ann Thorac Surg. 2006;81:2250-2257. doi: 10.1016/j.athoracsur.2005.11.041.
309. Jahangiri M, Zurakowski D, Bichell D, Mayer JE, del Nido PJ, Jonas RA. Improved results with selective management in pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1999;118:1046-1055. doi: 10.1016/S0022-5223(99)70100-5.
310. Rychik J, Levy H, Gaynor JW, DeCampli WM, Spray TL. Outcome after operations for pulmonary atresia with intact ventricular septum. J Thorac Cardiovasc Surg. 1998;116:924-931. doi: 10.1016/S0022-5223(98)70042-X.
311. Gilljam T, McCrindle BW, Smallhorn JF, Williams WG, Freedom RM. Outcomes of left atrial isomerism over a 28-year period at a single institution. J Am Coll Cardiol. 2000;36:908-916.
312. Hashmi A, Abu-Sulaiman R, McCrindle BW, Smallhorn JF, Williams WG, Freedom RM. Management and outcomes of right atrial isomerism: a 26-year experience. J Am Coll Cardiol. 1998;31:1120-1126.
313. Larsen RL, Eguchi JH, Mulla NF, Johnston JK, Fitts J, Kuhn MA, Razzouk AJ, Chinnock RE, Bailey LL. Usefulness of cardiac transplantation in children with visceral heterotaxy (asplenic and polysplenic syndromes and single right-sided spleen with levocardia) and comparison of results with cardiac transplantation in children with dilated cardiomyopathy. Am J Cardiol. 2002;89:1275-1279.